VONLEROLIZUMAB

UNII:	C78148TF1D
Formula:
Preferred Substance Name:	VONLEROLIZUMAB
GSRS Full Record:	C78148TF1D i

1638935-72-4
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TNFRSF4(TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 4, ACT35, OX40, CD134)), HUMANIZED MONOCLONAL ANTIBODY
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 4 (ACT35 ANTIGEN, OX40L RECEPTOR, CD134 ANTIGEN))HUMANIZED MOUSE MONOCLONAL ANTIBODY: .GAMMA.1 HEAVY CHAIN (1-447) (HUMANIZED MOUSE VH (HOMO SAPIENS IGHV1-46*01 (81%) (IGHD)-IGHJ6*01 (92%)) (8.8.10) (1-117) -HOMO SAPIENS IGHG1*03 (CH1 R97>K(214)) (118-447)) (220-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (HUMANIZED MOUSE V-KAPPA (HOMO SAPIENS IGKV1-39*01 (90%) IGKJ1*01) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*01 (108'-214')) DIMER (226-226'':229-229'')-BISDISULFIDE
MOXR0916
MOXR-0916
POGALIZUMAB
R07021608
R0-7021608
RG7888
RG-7888
VONLEROLIZUMAB [INN]
VONLEROLIZUMAB [USAN]
VONLEROLIZUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

VONLEROLIZUMAB

Synonyms and Mappings

Resources